| 000 | 01110 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515120616.0 | ||
| 264 | 0 | _c20080602 | |
| 008 | 200806s 0 0 eng d | ||
| 022 | _a1527-9995 | ||
| 024 | 7 |
_a10.1016/j.urology.2008.01.025 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThompson, Ian M | |
| 245 | 0 | 0 |
_aDoes the level of prostate cancer risk affect cancer prevention with finasteride? _h[electronic resource] |
| 260 |
_bUrology _cMay 2008 |
||
| 300 |
_a854-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aFinasteride _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aTangen, Catherine M | |
| 700 | 1 | _aParnes, Howard L | |
| 700 | 1 | _aLippman, Scott M | |
| 700 | 1 | _aColtman, Charles A | |
| 773 | 0 |
_tUrology _gvol. 71 _gno. 5 _gp. 854-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.urology.2008.01.025 _zAvailable from publisher's website |
| 999 |
_c17951508 _d17951508 |
||